Performance snapshot
TechAvidus presents as a broadly capable custom software, web, and mobile development firm with a strong track record across logistics, fintech, real estate, and insurance verticals. The majority of assessable categories rate Strong, anchored by multiple high-density reviews citing specific metrics such as a 35% engagement increase, 30% lead conversion uplift, and agile-driven milestone delivery. One notable negative review — describing missed deadlines and an incomplete MVP — introduces a Reliability flag that prevents a uniformly positive profile. Proactive communication gaps are a minor but recurring theme across several platforms.
Best for
TechAvidus is best suited for SMBs and mid-market firms seeking cost-effective custom software, CRM, web, and mobile development, particularly in logistics, fintech, real estate, and insurance sectors with budgets ranging from $10K to $200K.
Clients info
TechAvidus serves a diverse client base spanning logistics, fintech, insurance, real estate, education, and marketing sectors. Most clients are small to mid-sized businesses (1–200 employees), though engagements with firms of 5,000+ employees (e.g., Howden, Deutsche Bank) are also evidenced. Project budgets most commonly fall in the $10,000–$49,999 range, with select engagements reaching $50,000–$199,999 and above. Primary industries represented include Financial Services & Fintech, Logistics & Supply Chain, Real Estate, Insurance, Education, Marketing & Advertising. Typical client size bands include 1–10 Employees, 11–50 Employees, 51–200 Employees, 5,000+ Employees (select engagements). Common project budget ranges include Less than $10,000, $10,000 to $49,999, $50,000 to $199,999.
Review strength
The assessment draws on 72 reviews across 4 platforms, with the majority published between 2021 and 2025 and several reviews from 2024 and 2025 confirming recency. One review is dated July 2026, which appears to be a future-dated or erroneous entry and should be treated with caution. Reviews older than two years (pre-2023) are present but represent a minority of the evidence base. Review date range: 2021-02-22 - 2026-07-04.